CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer
Abstract Background Programmed death-ligand 1 (PD-L1) is an immunosuppressor that plays an important role in cancer treatments. Although majority of the studies demonstrated that PD-L1 expression was regulated by cellular intrinsic and extrinsic controls, and IFN-γ was a key molecule of extrinsic co...
Main Authors: | Chenlu Zhang, Zhi Li, Ling Xu, Xiaofang Che, Ti Wen, Yibo Fan, Ce Li, Shuo Wang, Yu Cheng, Xiaoxun Wang, Xiujuan Qu, Yunpeng Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-04-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-018-4384-8 |
Similar Items
-
The effect of transplantation of cultured autologous melanocytes on CXCL9, CXCL10 and CXCL11 expressions in vitiligo
by: Chen Xu, et al.
Published: (2023-01-01) -
CXCL9-11 chemokines and CXCR3 receptor in teleost fish species
by: Natalia Valdés, et al.
Published: (2022-12-01) -
The role of CXCR3 and its ligands in cancer
by: Xiaoming Wang, et al.
Published: (2022-11-01) -
CXCL8, CXCL9, CXCL10, and CXCL11 as biomarkers of liver injury caused by chronic hepatitis B
by: Xin Yu, et al.
Published: (2022-11-01) -
Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells
by: Christian Koch, et al.
Published: (2022-12-01)